Home / Share Price Target / Aplltd
Alembic Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Alembic Pharmaceuticals Limited | |||
 | Symbol: APLLTD | ||
| Price: ₹1,041.83 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Alembic Pharma Brief Company Overview
- 1.1: Alembic Pharmaceuticals Limited: A Trusted Name in Pharmaceuticals
- 1.2: Alembic Pharma Financial Performance
- 1.2.1: Is Alembic Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Alembic Pharma Share Price Target For 2024
- 2.1.1: Alembic Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Alembic Pharma Share Price Prediction For 2024
- 2.2: Alembic Pharma Share Price Target For 2025
- 2.2.1: Alembic Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Alembic Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Alembic Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Alembic Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Alembic Pharma Past Performance
Alembic Pharma Brief Company Overview
Alembic Pharmaceuticals Limited: A Trusted Name in Pharmaceuticals
Established in 1907, Alembic Pharmaceuticals Limited is a leading Indian pharmaceutical company with a global footprint.
The company offers a diverse range of branded specialty medicines in areas such as cardiology, gynecology, and ophthalmology. It also manufactures generic formulations in various categories, including oral solids, injectables, and ophthalmic products.
- Reputation: Alembic Pharmaceuticals Limited enjoys a strong reputation for quality and innovation within the industry.
- Commitment: The company is committed to providing affordable and accessible healthcare solutions to patients worldwide.
Alembic Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 20,422.95 Crore | Market valuation of Alembic Pharma's shares. |
| Revenue (TTM) | 6,304.21 Crore | Total revenue generated by Alembic Pharma over the past twelve months. |
| Net Income (TTM) | +629.92 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 10.74% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 9.99% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +5.09% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +11.7% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 10.65 | Company's total debt divided by total shareholder equity. |
| Total Debt | 513.15 Crore | Sum of Alembic Pharma's current & long-term financial obligations. |
| Total Cash | 120.2 Crore | Total amount of liquid funds available to Alembic Pharma. |
| Beta | 0.69 | Beta is less than 1 indicating that the Alembic Pharma's price is less volatile than the market. |
Is Alembic Pharma A Good Buy For Long Term?
No valid response content found
To predict the Alembic Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Alembic Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Alembic Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Alembic Pharma shares in 2024, see the table below.
Alembic Pharma Share Price Target Table For 2024
| Alembic Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 1068.49 (+2.55%) | Fibonacci Extension Level 199% |
| 2024 Target 2 | 1056.10 (+1.36%) | Technical Indicator: MA150 |
| 2024 Target 1 | 1045.00 (+0.3%) | Price Action: Jul 2020 High |
| Current Price | 1041.84 | Alembic Pharma's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 1040.09 (-0.17%) | Fibonacci Retracement Level 38.2% |
| Stop Loss 2 | 1027.90 (-1.34%) | Price Action: 28 Oct 2024 Low |
| Stop Loss 3 | 1017.15 (-2.37%) | Price Action: 12 Nov 2024 Low |
Summary: Alembic Pharma Share Price Prediction For 2024
In summary, Alembic Pharma has surged by ₹282.44, achieving a notable +37.19% increase from 1st January 2024 to 22 Nov 2024. Our analysis of Alembic Pharma for 2024 predicts an additional rise of 0.3% to 2.55% by the end of 2024 with three potential targets T1: 1045.00, T2: 1056.10, T3: 1068.49. Stop Loss at SL1: 1040.09, SL2: 1027.90, SL3: 1017.15.
Alembic Pharma has a 52-week high of ₹1303.90, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹710.25, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Alembic Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Alembic Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Alembic Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Alembic Pharma shares in 2025, see the table below.
Alembic Pharma Share Price Target Table For 2025
| Alembic Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 1404.81 (+34.83%) | Price Action: Chart |
| 2025 Target 2 | 1378.62 (+32.32%) | Price Action: Chart |
| 2025 Target 1 | 1364.97 (+31.01%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 1041.84 | Alembic Pharma's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 962.15 (-7.65%) | Price Action: May 2024 High |
| Stop Loss 2 | 945.50 (-9.25%) | Price Action: Apr 2021 Low |
| Stop Loss 3 | 933.50 (-10.4%) | Price Action: Feb 2024 Low |
Summary: Alembic Pharma Share Price Prediction For 2025
In summary, Alembic Pharma has surged by ₹282.44, achieving a notable +37.19% increase from 1st January 2024 to 22 Nov 2024. Our analysis of Alembic Pharma for 2025 predicts an additional rise of 31.01% to 34.83% by the end of 2025 with three potential targets T1: 1364.97, T2: 1378.62, T3: 1404.81. Stop Loss at SL1: 962.15, SL2: 945.50, SL3: 933.50.
Alembic Pharma has a All-Time high of ₹1303.90, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹710.25, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Alembic Pharma, we have created a specific page for that check here: Alembic Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Alembic Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Alembic Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 9.18% over the next 15 years.
For complete year by year Alembic Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Alembic Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Alembic Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹1,041.83 | [Current Price] |
| 2024 | ₹1,129.36 | 8.4% |
| 2025 | ₹1,379.87 | 22.18% |
| 2026 | ₹1,526.56 | 10.63% |
| 2027 | ₹1,709.88 | 12% |
| 2028 | ₹1,851.96 | 8.3% |
| 2029 | ₹2,042.4 | 10.28% |
| 2030 | ₹2,340.15 | 14.57% |
| 2031 | ₹2,459.11 | 5.08% |
| 2032 | ₹2,640.7 | 7.38% |
| 2033 | ₹2,761.14 | 4.56% |
| 2034 | ₹2,955.42 | 7.03% |
| 2035 | ₹3,300.42 | 11.67% |
| 2036 | ₹3,391.67 | 2.76% |
| 2037 | ₹3,571.52 | 5.3% |
| 2038 | ₹3,670.32 | 2.76% |
| 2039 | ₹3,863.09 | 5.25% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Alembic Pharma Past Performance
- In 2011, Alembic Pharma opening price was ₹40.04
- As of Fri 22 Nov 2024 the price stands at ₹1,041.83.
- This represents a Compound Annual Growth Rate (CAGR) of 26.21%.
- In 13 years, an investment of 10,000 would have become ₹2.6 Lakh.
As we wrap up, we hope you like our study on Alembic Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Alembic Pharma Share Price History
- Alembic Pharma Price Target Tomorrow
- Alembic Pharma Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
